Biomimetism and Regenerative Medicine Team (BRM)
Invasion Mechanisms in Angiogenesis and Cancer team (IMAC)
Mechanisms of Angiogenesis in Biological Barriers team (MAB2)
highlight / actuality
As part of anti-proliferative therapies, we have developed a genetic screening of aptamer peptides in order to identify interactors of the regulatory subunit ß of the protein kinase CK2. This subunit is involved in the regulation of many cellular processes such as homeostasis between proliferation and cell death.
Highlight available in French.
Martel V, Filhol O, Colas P and Cochet C
p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.